| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |